Endurant Capital Management LP - ARRAY BIOPHARMA INC ownership

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$401,000
-72.5%
16,447
-83.9%
0.16%
-79.4%
Q4 2018$1,458,000
-14.9%
102,345
-9.2%
0.77%
+1.2%
Q3 2018$1,713,000
+25.4%
112,700
+38.4%
0.76%
+28.7%
Q2 2018$1,366,000
+17.3%
81,416
+14.0%
0.59%
+36.1%
Q1 2018$1,165,000
+79.8%
71,400
+41.1%
0.44%
+119.7%
Q4 2017$648,000
-42.1%
50,600
-44.4%
0.20%
-41.6%
Q3 2017$1,119,000
+59.6%
91,000
+8.7%
0.34%
+71.2%
Q2 2017$701,000
+183.8%
83,700
+197.9%
0.20%
+94.1%
Q4 2016$247,000
+263.2%
28,100
+181.0%
0.10%
+308.0%
Q3 2016$68,00010,0000.02%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders